Stewart Julian M, Sutton Richard, Kothari Mira L, Goetz Amanda M, Visintainer Paul, Medow Marvin Scott
Departments of Pediatrics, New York Medical College, Valhalla, New York, USA.
Departments of Physiology, New York Medical College, Valhalla, New York, USA.
Heart. 2017 Nov;103(21):1711-1718. doi: 10.1136/heartjnl-2017-311161. Epub 2017 May 13.
Syncope is sudden transient loss of consciousness and postural tone with spontaneous recovery; the most common form is vasovagal syncope (VVS). We previously demonstrated impaired post-synaptic adrenergic responsiveness in young VVS patients was reversed by blocking nitric oxide synthase (NOS). We hypothesised that nitric oxide may account for reduced orthostatic tolerance in young recurrent VVS patients.
We recorded haemodynamics in supine VVS and healthy volunteers (aged 15-27 years), challenged with graded lower body negative pressure (LBNP) (-15, -30, -45 mm Hg each for 5 min, then -60 mm Hg for a maximum of 50 min) with and without NOS inhibitor N-monomethyl-L-arginine acetate (L-NMMA). Saline plus phenylephrine (Saline+PE) was used as volume and pressor control for L-NMMA.
Controls endured 25.9±4.0 min of LBNP during Saline+PE compared with 11.6±1.4 min for fainters (p<0.001). After L-NMMA, control subjects endured 24.8±3.2 min compared with 22.6±1.6 min for fainters. Mean arterial pressure decreased more in VVS patients during LBNP with Saline+PE (p<0.001) which was reversed by L-NMMA; cardiac output decreased similarly in controls and VVS patients and was unaffected by L-NMMA. Total peripheral resistance increased for controls but decreased for VVS during Saline+PE (p<0.001) but was similar following L-NMMA. Splanchnic vascular resistance increased during LBNP in controls, but decreased in VVS patients following Saline+PE which L-NMMA restored.
We conclude that arterial vasoconstriction is impaired in young VVS patients, which is corrected by NOS inhibition. The data suggest that both pre- and post-synaptic arterial vasoconstriction may be affected by nitric oxide.
晕厥是指意识和姿势张力突然短暂丧失并能自发恢复的情况;最常见的形式是血管迷走性晕厥(VVS)。我们之前证明,通过阻断一氧化氮合酶(NOS)可逆转年轻VVS患者突触后肾上腺素能反应性受损的情况。我们推测一氧化氮可能是导致年轻复发性VVS患者直立耐力降低的原因。
我们记录了仰卧位VVS患者和健康志愿者(年龄15 - 27岁)的血流动力学情况,在有和没有NOS抑制剂N - 单甲基 - L - 精氨酸乙酸盐(L - NMMA)的情况下,对他们进行分级下肢负压(LBNP)挑战(每次-15、-30、-45 mmHg,持续5分钟,然后-60 mmHg,最长持续50分钟)。使用生理盐水加去氧肾上腺素(生理盐水+去氧肾上腺素)作为L - NMMA的容量和升压对照。
在生理盐水+去氧肾上腺素期间,对照组耐受LBNP的时间为25.9±4.0分钟,而晕厥者为11.6±1.4分钟(p<0.001)。给予L - NMMA后,对照组受试者耐受时间为24.8±3.2分钟,晕厥者为22.6±1.6分钟。在生理盐水+去氧肾上腺素进行LBNP期间,VVS患者的平均动脉压下降得更多(p<0.001),L - NMMA可使其逆转;对照组和VVS患者的心输出量下降情况相似,且不受L - NMMA影响。在生理盐水+去氧肾上腺素期间,对照组的总外周阻力增加,而VVS患者则下降(p<0.001),但在给予L - NMMA后两者相似。在LBNP期间,对照组的内脏血管阻力增加,但在VVS患者中,生理盐水+去氧肾上腺素后内脏血管阻力下降,L - NMMA可使其恢复。
我们得出结论,年轻VVS患者的动脉血管收缩功能受损,通过抑制NOS可得到纠正。数据表明,突触前和突触后的动脉血管收缩可能均受一氧化氮影响。